Comparison Between 1st Generation Egfr Tyrosine Kinase Inhibitor (Gefitinib) Versus 2nd Generation (Afatinib) In Egfr-Mutated Non-Small Cell Lung Cancers (Nsclc) - Real World Experience
LUNG CANCER(2021)
Key words
gefitinib,afatinib,egfr-mutated,non-small
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined